Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Pediatric Transplants

Reduced intensity conditioning in unrelated donor transplantation for refractory cytopenia in childhood

Bone Marrow Transplantation volume 40, pages 329–333 (2007)Cite this article

Abstract

Myelodysplastic syndromes (MDS) are a heterogenous group of acquired hematopoietic stem cell disorders. Refractory cytopenia (RC) is the most common subtype of childhood MDS and hematopoietic stem cell transplantation (HSCT) is the only curative treatment. HSCT following a myeloablative preparative regimen is associated with a low probability of relapse and considerable transplant-related mortality. In the present European Working Groups of MDS pilot study, we investigated whether a reduced intensity conditioning regimen (RIC) is able to offer reduced toxicity without increased rates of graft failure or relapse. Nineteen children with RC were transplanted from an unrelated donor following RIC consisting of fludarabine, thiotepa and anti-thymocyte globulin. Three patients experienced graft failure. Neutrophil and platelet engraftment occurred at a median time of 23 and 30 days, respectively. Cumulative incidence of grade II–IV and grade III and IV acute graft-versus-host disease (GVHD) was 0.48 and 0.13, respectively; three patients developed extensive chronic GVHD. Although infections were the predominant complications, only one patient with extensive chronic GVHD died from infectious complications. Overall and event-free survival at 3 years were 0.84 and 0.74, respectively. In conclusion, our results were comparable to those of patients treated with myeloablative HSCT. Long-term follow-up is needed to demonstrate the expected reduction in long-term sequelae.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Hasle H, Niemeyer CM, Chessells JM, Baumann I, Bennett JM, Kerndrup G et al. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia 2003; 17: 277–282.

    Article  CAS  PubMed  Google Scholar 

  2. Pui CH, Schrappe M, Ribeiro RC, Niemeyer CM . Childhood and adolescent lymphoid and myeloid leukemia. Hematology Am Soc Hematol Educ Program 2004, 118–145.

    Article  Google Scholar 

  3. Kardos G, Baumann I, Passmore SJ, Locatelli F, Hasle H, Schultz KR et al. Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7. Blood 2003; 102: 1997–2003.

    Article  CAS  PubMed  Google Scholar 

  4. Locatelli F, Zecca M, Zintl F, Nürnberger W, Ebell W, Niethammer D et al. Busulfan, cyclophosphamide and melphalan as preparative regimen to allogeneic stem cell transplantation in childhood MDS: results of the second interim analysis of the EBMT/EWOG-MDS study. Bone Marrow Transplant 2001; 27 (Suppl 1): S69–S70.

    Google Scholar 

  5. Yusuf U, Frangoul HA, Gooley TA, Woolfrey AE, Carpenter PA, Andrews RG et al. Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience. Bone Marrow Transplant 2004; 33: 805–814.

    Article  CAS  PubMed  Google Scholar 

  6. Storb R, Yu C, Wagner JL, Deeg HJ, Nash RA, Kiem HP et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 1997; 89: 3048–3054.

    CAS  PubMed  Google Scholar 

  7. McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001; 97: 3390–3400.

    Article  CAS  PubMed  Google Scholar 

  8. Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, Cividalli G et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756–763.

    CAS  PubMed  Google Scholar 

  9. Cantu-Rajnoldi A, Fenu S, Kerndrup G, van Wering ER, Niemeyer CM, Baumann I . Evaluation of dysplastic features in myelodysplastic syndromes: experience from the morphology group of the European Working Group of MDS in Childhood (EWOG-MDS). Ann Hematol 2005; 84: 429–433.

    Article  CAS  PubMed  Google Scholar 

  10. Bader P, Niemeyer C, Willasch A, Kreyenberg H, Strahm B, Kremens B et al. Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre-emptive immunotherapy. Br J Haematol 2005; 128: 649–658.

    Article  PubMed  Google Scholar 

  11. Locatelli F, Nollke P, Zecca M, Korthof E, Lanino E, Peters C et al. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. Blood 2005; 105: 410–419.

    Article  CAS  PubMed  Google Scholar 

  12. Storb R, Prentice RL, Sullivan KM, Shulman HM, Deeg HJ, Doney KC et al. Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Ann Intern Med 1983; 98: 461–466.

    Article  CAS  PubMed  Google Scholar 

  13. Gooley TA, Leisenring W, Crowley J, Storer BE . Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999; 18: 695–706.

    Article  CAS  PubMed  Google Scholar 

  14. Horn B, Baxter-Lowe LA, Englert L, McMillan A, Quinn M, Desantes K et al. Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML. Bone Marrow Transplant 2006; 37: 263–269.

    Article  CAS  PubMed  Google Scholar 

  15. Woodard P, Tong X, Richardson S, Srivastava DK, Horwitz EM, Benaim E et al. Etiology and outcome of graft failure in pediatric hematopoietic stem cell transplant recipients. J Pediatr Hematol Oncol 2003; 25: 955–959.

    Article  PubMed  Google Scholar 

  16. Del Toro G, Satwani P, Harrison L, Cheung YK, Brigid BM, George D et al. A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients. Bone Marrow Transplant 2004; 33: 613–622.

    Article  CAS  PubMed  Google Scholar 

  17. Jacobsohn DA, Duerst R, Tse W, Kletzel M . Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children. Lancet 2004; 364: 156–162.

    Article  PubMed  Google Scholar 

  18. Shenoy S, Grossman WJ, DiPersio J, Yu LC, Wilson D, Barnes YJ et al. A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders. Bone Marrow Transplant 2005; 35: 345–352.

    Article  CAS  PubMed  Google Scholar 

  19. Cohen J, Gandhi M, Naik P, Cubitt D, Rao K, Thaker U et al. Increased incidence of EBV-related disease following paediatric stem cell transplantation with reduced-intensity conditioning. Br J Haematol 2005; 129: 229–239.

    Article  PubMed  Google Scholar 

  20. Bhatia S, Ramsay NK, Steinbuch M, Dusenbery KE, Shapiro RS, Weisdorf DJ et al. Malignant neoplasms following bone marrow transplantation. Blood 1996; 87: 3633–3639.

    CAS  PubMed  Google Scholar 

  21. Curtis RE, Travis LB, Rowlings PA, Socie G, Kingma DW, Banks PM et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood 1999; 94: 2208–2216.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric Hematology and Oncology, Center for Pediatric and Adolescent Medicine, University of Freiburg, Freiburg, Germany

    B Strahm & C M Niemeyer

  2. Pediatric Hematology-Oncology, University of Pavia, IRCCS Policlinico San Matteo, Pavia, Italy

    F Locatelli

  3. Pediatric Hematology and Oncology, Center of Pediatric and Adolescent Medicine, University of Frankfurt am Main, Frankfurt, Germany

    P Bader

  4. Department of Pediatric Hematology and Oncology, University of Münster, Münster, Germany

    K Ehlert

  5. Department of Pediatric Hematology-Oncology and Endocrinology, University of Essen, Essen, Germany

    B Kremens

  6. Department for Hematology and Oncology, Hospital for Pediatric and Adolescent Medicine, Friedrich-Schiller-University, Jena, Germany

    F Zintl

  7. Pediatric Hematology and Oncology, Dr von Haunersches Childrens Hospital, Ludwig-Maximilians University, Munich, Germany

    M Führer

  8. Hospital for Pediatric and Adolescent Medicine, University of Erlangen, Erlangen, Germany

    D Stachel

  9. Pediatric Hematology and Oncology, Medical School Hannover, Hannover, Germany

    K-W Sykora

  10. Department of Pediatric Hematology and Oncology, University Hospital Motol, Prague, Czech Republic

    P Sedlacek

  11. Institute of Pathology, University of Erlangen, Erlangen, Germany

    I Baumann

Authors
  1. B Strahm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F Locatelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P Bader
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K Ehlert
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B Kremens
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F Zintl
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M Führer
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. D Stachel
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. K-W Sykora
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. P Sedlacek
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. I Baumann
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. C M Niemeyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

on behalf of the EWOG-MDS Study Group

Corresponding author

Correspondence to B Strahm.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Strahm, B., Locatelli, F., Bader, P. et al. Reduced intensity conditioning in unrelated donor transplantation for refractory cytopenia in childhood. Bone Marrow Transplant 40, 329–333 (2007). https://doi.org/10.1038/sj.bmt.1705730

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705730

Keywords

This article is cited by

Search

Advanced search

Quick links